Pediatric Blood & Cancer

Article	Citations
	80
	49
	42
	41
Shwachman–Diamond Syndrome Patient Progressing From Chronic Myelomonocytic Leukemia to Acute Myeloid Leukemia within Two Months	39
Comparing Absolute Neutrophil Counts of Children With Sickle Cell Disease With and Without the Duffy Null Phenotype	38
	38
Implementation of physical rehabilitation programs for children with cancer across low‐ and middle‐income countries: A need of the hour perspective	37
Recombinant von Willebrand factor for perioperative bleeding management in pediatric patient with allergy to plasma‐derived von Willebrand factor	34
Palliative care and suicidality: Complicated conversations at two ends of the spectrum	33
Late mortality reduction among survivors of germ cell tumors in childhood and adolescence in Europe: A report from the PanCareSurFup cohort	32
Brochure intervention to manage bothersome taste changes in pediatric patients receiving cancer therapy	31
Feasibility of treating pediatric intracranial germ cell tumors in a middle‐income country: The Jordanian experience	28
Metastatic and multiply relapsed SDH‐deficient GIST and paraganglioma displays clinical response to combined poly ADP‐ribose polymerase inhibition and temozolomide	28
Late‐onset lymphopenia during radiation is associated with an increased risk of tumor recurrence in newly diagnosed pediatric medulloblastoma	26
Choriocarcinoma in neonates and infants: A severe but curable disease	25
Response assessment by positron emission tomography‐computed tomography as compared with contrast‐enhanced computed tomography in childhood Hodgkin lymphoma can reduce the need for radiotherapy in low	25
Refractory thrombocytopenia and myelofibrosis in a novel KDSR mutation: Case report and literature review	25
Central nervous system thrombosis in pediatric acute lymphoblastic leukemia in Turkey: A multicenter study	24
Cabozantinib in children with recurrent diffuse gliomas	24
Neonatal giant axillary hemangioma with subclavian arteriovenous fistula and heart failure	24
The role of neoadjuvant chemotherapy in the management of metastatic central nervous system germinoma: A meta‐analysis	23
Children's Oncology Group 2023 blueprint for research: Cancer care delivery research	23
Psychosexual functioning in cancer survivorship: What the pediatric oncologist needs to know	23
ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infant	23

Image‐Guided Biopsy for the Diagnosis and Molecular Profiling of Hepatoblastoma	22
Efficacy of dual‐task training on stability and function in children with ataxia after medulloblastoma resection: A randomized controlled trial	22
Global nLPHL One Working Group (GLOW) Research Roadmap for Nodular Lymphocyte‐Predominant Hodgkin Lymphoma	21
After 75 Years of Methotrexate, Can Treatment Results Be Improved With Appropriate Folinic Acid Rescue?	21
The Ukrainian children emergency: How the Pediatric Oncology Unit of Turin supports cancer patients and their families who have escaped war	21
Impact of Food Insecurity on Malnutrition Treatment Response in Nigerian Children With Sickle Cell Anemia and Severe Acute Malnutrition	21
Incidence and 5‐year survival of children and adolescents with hepatoblastoma in the United States	21
Bloodletting as Medical Child Abuse Revealed by Lack of Iron Accumulation Despite Multiple Erythrocyte Transfusions	21
No wrong decisions in an all‐wrong situation. A qualitative study on the lived experiences of families of children with diffuse intrinsic pontine glioma	20
Bone mineral density in primarily preadolescent children with hemoglobin E/β‐thalassemia with different severities and transfusion requirements	20
Durable changes in the gut microbiome in survivors of childhood acute lymphoblastic leukemia	19
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors	19
Outcomes of Wilms tumor therapy in Lilongwe, Malawi, 2016–2021: Successes and ongoing research priorities	19
How we approach complex vascular anomalies and overgrowth syndromes	19
Fatal brainstem injury following proton radiation in a patient with medulloblastoma and a germline variant in RNF213	19
Glomerular filtration rate in children and young adults with haemato‐oncological disease and infection is best described by three‐compartment iohexol model	19
Strategies for the Treatment of Desmoplastic Small Round Cell Tumor: A Case Series	19
Social determinants of neurocognitive and academic performance in sickle cell disease	18
A three‐year‐old with central nervous system graft versus host disease: A rare cause of posthematopoietic stem cell transplant encephalopathy	18
A randomized double‐blind placebo‐controlled trial of the effectiveness of melatonin on neurocognition and sleep in survivors of childhood cancer	18
A community‐based trial of a psychosocial eHealth intervention for parents of children with cancer	18
KMT2A‐MAML2 rearrangement emerged and regressed during neuroblastoma therapy without leukemia after 12.8‐year follow‐up	18
Kaposiform hemangioendothelioma of the bone in children and adolescents	18
Radiation recall reaction induced by gemcitabine/docetaxel in children: A retrospective study on risk factors and outcomes	18
Luspatercept for non‐deletional hemoglobin H disease	18
Rapid symptomatic improvement in two patients with ganglioglioma after restarting BRAF inhibitor therapy	18
Mini‐hyper CVD + CRIB (condensed rituximab, inotuzumab ozogamicin, and blinatumomab) for refractory pediatric B‐acute lymphoblastic leukemia	17
Prognostic factors of sepsis in children with acute leukemia admitted to the pediatric intensive care unit	17
Platelet changes and bleeding symptoms in children, adolescents, and adults with 22q11.2 deletion syndrome	17
Quality of life and late therapy effects in pediatric non‐Hodgkin lymphoma survivors: Insights from a single‐institution study	17
Lactate dehydrogenase reflects the status of ultra‐high‐risk neuroblastoma in a child under treatment	17
Ultrastructural investigation on pseudo Chediak–Higashi abnormality in acute lymphoblastic leukemia: A case report	17
High‐dose carboplatin–irinotecan–temozolomide is an effective salvage chemotherapy for relapsed or refractory neuroblastoma	17
Automating the treatment planning process for 3D‐conformal pediatric craniospinal irradiation therapy	16
Feasibility of indocyanine green‐guided localization of pulmonary nodules in children with solid tumors	16
Benchmarks for Psychosocial Staffing in Pediatric Oncology: Implementing the Standards Together—Engaging Parents and Providers in Psychosocial Care (iSTEPPP) Study	16
Pediatric erythroblastic transformation of JAK2‐mutated prefibrotic primary myelofibrosis with concurrent PHF6 mutations	16
Significance of fusion status, Oberlin risk factors, local and maintenance treatment in pediatric and adolescent patients with metastatic rhabdomyosarcoma: Data of the European Soft Tissue Sarcoma Reg	16
Prevalence of Duffy null and its impact on hydroxyurea in young children with sickle cell disease in the United States	15
Ring sideroblasts and macrocytic anemia in an infant: Clues to the diagnosis of Pearson syndrome	15
Comment on: Incorporation of patient‐reported outcomes in early‐phase clinical trials for childhood and adolescent cancer	15
	15
Mesial temporal pilocytic astrocytoma compressing brainstem: Clinical cure after stereotactically inserted Ommaya and radiosurgery‐induced shrinkage	15
Issue Information	15
	15
Desensitization with daratumumab in a pediatric patient with thalassemia major and high donor‐specific antibody prior to haploidentical transplantation	15
Diminished ovarian reserve in adolescent cancer survivors treated with heavy metal chemotherapy	15
Resource‐appropriate selection of osteosarcoma treatment protocols in low‐ and middle‐income countries	14
Clinical characteristics and outcomes of SARS‐CoV‐2 infection in pediatric oncology patients in the province of Quebec	14
Brentuximab vedotin as a single agent in the treatment of a pediatric primary cutaneous CD30+ lymphoproliferative disorder: A case report	14

Mexiletine: An adjuvant option for refractory pain in patients with sickle cell disease and comorbid autism spectrum disorder	14
Survival of pediatric patients requiring admission in the intensive care unit post hematopoietic stem cell transplantation: Prognostic factors associated with mortality	14
Implementation science in pediatric oncology: A narrative review and future directions	14
Platelet transfusions in neonates—Unresolved aspects and future directions	14
Case report: Dichloroacetate‐induced methaemoglobinaemia in a G6PD‐deficient neonate	14
Concurrent carcinocythemia, chest wall and right knee joint involvement in Ewing sarcoma	14
A qualitative exploration of parental caregivers’ experience caring for children who have survived medulloblastoma	14
Astrovirus VA1/HMO encephalitis after allogeneic hematopoietic cell transplantation: Significant role of immune competence in virus control	14
Fusion transcripts as liquid biopsy markers in alveolar rhabdomyosarcoma and synovial sarcoma: A report of the Cooperative Weichteilsarkom Studiengruppe (CWS)	13
Unraveling Juvenile Hyaline Fibromatosis: A Case of Novel ANTXR2 Mutations Associated with Subcutaneous Masses and Hydronephrosis	13
Correction to: Applying the COM‐B model to patient‐reported barriers to medication adherence in pediatric acute lymphoblastic leukemia	13
Stomatocytes, a whistleblower for future familial cardiovascular events: Unraveling the diagnosis of sitosterolemia in an Indian family	13
Posterior Mediastinal Tumor Presenting with Compressive Myelopathy: Uncommon Site for a Rare Tumor	13
A strategic approach to integration of spiritual care into the standards for the psychosocial care of children with cancer and their families	13
CIC–NUTM1 sarcoma in an 8‐year‐old female patient with a new fusion: A case report	13
B‐cell lymphoblastic leukemia in an adolescent with Dravet syndrome	13
In vivo evaluation of the lysine‐specific demethylase (KDM1A/LSD1) inhibitor SP‐2577 (Seclidemstat) against pediatric sarcoma preclinical models: A report from the Pediatric Preclinical Testing Consor	13
Successful Erwinia asparaginase one‐bag rapid desensitization process in a pediatric patient with acute lymphoblastic leukemia	13
Parental Acceptance of Human Papillomavirus Vaccination Among Females Treated for Childhood Cancer and/or With Hematopoietic Stem Cell Transplantation: A Cross‐Sectional Study	13
Variant histology of pediatric nodular lymphocyte‐predominant Hodgkin lymphoma with IgD and CD30 expression	13
Dyadic coping experiences of parents of children with vascular anomalies	13
How we approach coagulopathy with vascular anomalies	13
Image‐defined risk factors in localized thoracic neuroblastoma and ganglioneuroma	13
Assessment of Caregivers and Their Children With Cancer Regarding Information Provided by Healthcare Teams: Advancing Stages Toward the Creation of a Structured Education Program at the National Level	12
Pediatric Mixed Phenotype Acute Leukemia With ETV6::ARNT Fusion Gene Successfully Treated by Allogeneic Hematopoietic Stem Cell Transplantation	12
Uniting for Change: The GLOW Initiative and Its Impact on Nodular Lymphocyte‐Predominant Hodgkin Lymphoma	12
Treatment Landscape in Pediatric Immune Thrombocytopenia: Addressing Unmet Needs	12
Prognostic value of texture analysis of the primary tumour in high‐risk neuroblastoma: An 18F‐DOPA PET study	12
Shifting perspectives and transformative change: Parent perspectives of an active music engagement intervention for themselves and their child with cancer	12
Age‐ and sex‐specific rates of gall bladder disease in children with sickle cell disease	12
A proposed algorithm for evaluation and management of pediatric hemophilia patients who present to the emergency department with head trauma	12
Diagnosis, monitoring, and management of pyruvate kinase deficiency in children	12
Paraneoplastic Ichthyosis Preceding the Diagnosis of Gluteal Rhabdomyosarcoma at Initial Presentation and Relapse	12
Survey of the use of traditional and complementary medicine among children with cancer at three hospitals in Cameroon	12
Inclusion of Optic Pathway and Hypothalamic Tumors in Prognostic Studies of Pilocytic Astrocytoma: Is It Justified?	12
Incidence and survival for childhood cancer by endorsed non‐stage prognostic indicators in Australia	12
Allogenic haematopoeitic stem cell transplant as cure for severe transfusion‐dependent non‐dominant hereditary spherocytosis due to homozygous SPTA1 mutation	12
Novel ELANE mutation causing severe congenital neutropenia with unpredictable fluctuations in neutrophil counts	12
Sarcopenia in long‐term survivors of cancer in childhood and adolescence: A cross‐sectional study of calf muscle mass by peripheral quantitative computed tomography with an examination of the muscle–b	12
The Role of Perceived Health‐Related Information Adequacy in the Experiences of Parents of Children With Complex Vascular Anomalies	12
Baseline Characteristics of Parents Enrolled in Children's Oncology Group Study ACCL20N1CD: Financial Toxicity During Treatment for Pediatric Acute Lymphoblastic Leukemia in the United States	12
Bone marrow hematoidin crystals in a pediatric patient with chondroblastic osteosarcoma	12
Abnormal coronary hyperperfusion due to a giant hemangioendothelioma in fetal distress: A case report	12
First‐Line Postremission Blinatumomab as Successful Toxicity‐Sparing Strategy in a Boy with Cystic Fibrosis and Acute Lymphoblastic Leukemia	12
Efficacy and safety of azacitidine in pediatric patients with newly diagnosed advanced myelodysplastic syndromes before hematopoietic stem cell transplantation in the AZA‐JMML‐001 trial	11
Pulmonary hypertension screening in children with sickle cell disease	11
Wilms tumor characteristics, surgical management, outcomes, and chronic kidney disease in children with WAGR syndrome: A report from the International WAGR Syndrome Association survey	11
Epidemiology of clinically unsuspected venous thromboembolism in children with cancer: A population‐based study from Maritimes, Canada	11
Corrigendum	11
Good engraftment after reduced intensity targeted busulfan‐based conditioning and matched related donor hematopoietic cell transplantation in hemoglobinopathies	11
Thalidomide‐associated autoimmune hemolytic anemia	11
Characterization of KMT2A::MATR3 fusion in a patient with acute lymphoblastic leukemia and monitoring of minimal residual disease by nanoplate digital PCR	11
Correlation between asparaginase enzyme activity levels and coagulation parameters during childhood acute lymphoblastic leukemia treatment	11
The evidence is mounting: Insurance coverage disruptions lead to worse outcomes among children diagnosed with cancer	11
Genetic characteristics and treatment outcome in infants with KMT2A germline B‐cell precursor acute lymphoblastic leukemia: Results of MLL‐Baby protocol	11
Thrombin activatable fibrinolysis inhibitor plasma levels and TAFI Thr325Ile genetic polymorphism in a cohort of Egyptian sickle cell disease patients and impact on disease severity	11
SNAP: Supportive non‐invasive ventilation for acute chest syndrome prevention for hospitalized children with sickle cell disease: Perspectives of patients, parents, and the healthcare team	11
Philadelphia chromosome‐like B‐acute lymphoblastic leukemia and disseminated juvenile xanthogranulomatosis with shared KRAS mutation	11
Blood counts in children with Down syndrome	11
De novo antiphospholipid antibody syndrome in two infants	11
Eculizumab for management of hyperhemolysis syndrome in pediatric patients with sickle cell disease: A single‐center case series	11
Successful hematopoietic stem cell transplantation in MYH9‐related congenital thrombocytopenia	11
Spinal Atypical Teratoid/Rhabdoid Tumor with Metastatic Lesions in the Bilateral Acoustic Nerves	11
Sirolimus for management of GI bleeding in blue rubber bleb nevus syndrome: A case series	11
Refractory, fatal autoimmune hemolytic anemia due to ineffective thymic‐derived T‐cell reconstitution following allogeneic hematopoietic cell transplantation for hypomorphic RAG1 deficiency	11
Wiskott–Aldrich syndrome protein expression in female WAS carriers: A flow cytometry study from North India	11
Provision of a personalized survivorship care plan and its impact on cancer‐related health literacy among childhood cancer survivors in Hong Kong	11
Challenge implementing Pediatric Early Warning Systems to improve early identification of clinical deterioration in hospitalized children with cancer: Is it the score?	11
Treatment of newly diagnosed severe aplastic anemia in children: Evidence‐based recommendations	11
FANCC and PTCH1 gene loss in congenital infantile rhabdomyosarcoma with spindle cell features	11
Time to diagnosis among young patients with cancer	11
Spontaneous regression of a greater than 5 cm infant neuroblastoma after a three‐fold volume increase without life‐ or organ‐threatening features	10
Poor prognosis of B‐cell acute lymphoblastic leukemia with TCF/PBX1 fusion gene and ovarian involvement at diagnosis: Two case reports and review of the literature	10
Marginal Zone B‐Cell Lymphoma With Marked Plasmacytic Differentiation and Increased Large Cells in a Teenage Male With Serine/Threonine Kinase‐4 Deficiency	10
Pediatric refractory immune thrombocytopenia: A systematic review	10
Pediatric cancer care in Africa: SIOP Global Mapping process	10
Recurrent thrombosis with a mispositioned stent after treatment of an adolescent with May–Thurner syndrome	10
Programmed cell death protein blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation in an adolescent patient	10
Atypical presentations of RECQL4‐related syndromes	10
Feasibility of telehealth exercise and nicotinamide riboside supplementation in survivors of childhood cancer at risk for diabetes: A pilot randomized controlled trial	10

Location of death and hospice use in children with cancer varies by type of health insurance	10
Cytarabine dose reduction in patients with low‐risk acute myeloid leukemia: A report from the Children's Oncology Group	10
Pain mitigation and management strategies for anti‐GD2 infusions: An expert consensus	10
Transatlantic progress in measurement of cognitive outcomes in paediatric oncology trials	10
Surgical aspects and outcomes after nephrectomy for Wilms tumour in sub‐Saharan Africa: A report from Wilms Africa Phase II—CANCaRe Africa	10
Comment on: A Comparative Analysis of Clinical Utility of Cytogenetics and Copy‐Number–Integrated Risk Stratification Scores in a Prospective Cohort of Pediatric B‐Cell Acute Lymphoblastic Leukemia	10
Cancer does not wait: Safeguarding care for pediatric acute lymphoblastic leukemia patients during the COVID‐19 pandemic in a Mexican hospital	10
Contemporary surgical management of pediatric non‐rhabdomyosarcoma soft tissue sarcoma	10
Modern surgical strategies in pediatric neuroblastoma: Evolving approaches and treatment principles	10
Intra‐abdominal desmoplastic small round cell tumor: The European pediatric Soft tissue sarcoma Study Group (EpSSG) experience	10
Comprehensive fertility preservation can be offered in a timely manner around gonadotoxic therapy in children and adolescents	10
Introduction to fertility preservation in pediatric patients with cancer: A report from the Children's Oncology Group	10
Results of a Randomized Augmented Intensification Phase in Acute Lymphoblastic Leukemia in Children in Argentina: GATLA 2010 ALL IC Trial	10
Long‐term outcomes among survivors of childhood osteosarcoma: A report from the Childhood Cancer Survivor Study (CCSS)	10
Impact of magnetic resonance angiography parameters on stroke prevention therapy in pediatric patients with sickle cell anemia	10
How we approach genetics in the diagnosis and management of vascular anomalies	10
Neuroblastoma with neonatal cardiogenic shock and multiple‐organ failure: A rare association	10
Congenital rhabdomyosarcoma: A report from the European paediatric Soft tissue sarcoma Study Group	10
Daratumumab‐induced minimal residual disease negative remission in CD38 (dim)‐positive pediatric acute myeloid leukemia	10
Complete response of metastatic alveolar soft part sarcoma in an adolescent female treated by combined immune checkpoint inhibitors	9
Associations between Medicaid enrollment and diagnosis stage and survival among pediatric cancer patients	9
A comprehensive assessment of the prolonged febrile neutropenia evaluation in pediatric oncology patients	9
Clinical Practice Guideline for the Management of Communication and Swallowing in Children Diagnosed With Childhood Brain Tumor or Leukemia	9
How we approach lymphedema in the pediatric population	9
EZH2 is a key component of hepatoblastoma tumor cell growth	9
An SRF‐rearranged malignant cellular myoid neoplasm with a novel SRF–MKL2 fusion	9
Behavioral and Electrophysiological Assessment of Central Auditory Processing in Individuals With Sickle Cell Disease	9
Pneumatosis intestinalis in the pediatric oncology population: An 11‐year retrospective review at Memorial Sloan Kettering Cancer Center	9
Clinic reported facilitators and barriers to pediatric cancer survivor care delivery among survivorship clinics: A fishbone analysis	9
Intraventricular topotecan in the successful treatment of recurrent CNS pleuropulmonary blastoma	9
Abstracts from the 39th Annual Meeting of the Histiocyte Society	9
Lack of benefit from premedication for pegylated asparaginase during pediatric acute lymphoblastic leukemia/lymphoma therapy: A side‐by‐side comparison	9
Pre‐transplant glomerular hyperfiltration is not a risk factor for increased renal morbidity and mortality in pediatric stem cell transplant patients	9
Contemporary Biology, Management, and Outcomes of Renal Medullary Carcinoma in Children and Adults: A Pediatric Surgical Oncology Research Collaborative Study	9
Treatment of high‐risk Hodgkin lymphoma with a modified Stanford V regimen in the AHOPCA: Substituting chemotherapy agents and hampered outcomes	9
Prevalence of neuropathic pain in adolescents with sickle cell disease: A single‐center experience	9
Risk of Metabolic Syndrome and Glucose Homeostasis Among Childhood and Young Adult Acute Lymphoblastic Leukemia Survivors: Part of the ALL‐STAR Study	9
Acute exacerbation of graft‐versus‐host disease following SARS‐CoV2 infection after hematopoietic stem cell transplant in two pediatric patients	9
Cognitive predictors of social adjustment in pediatric brain tumor survivors treated with photon versus proton radiation therapy	9
A novel mobile health application to support cancer surveillance needs of patients and families with cancer predisposition syndromes	9
Socioeconomic Factors Associated With Participation in Postmortem Tissue Donation in Pediatric Central Nervous System Tumors	9
Addition of arm anthropometry to body mass index for age, but not serum albumin, improves the accuracy of the nutritional assessment in severely and moderately malnourished children with cancer	9
Chemotherapy‐induced thrombocytopenia in Ewing sarcoma: Implications and potential for romiplostim supportive care	9
The quality and content analysis of YouTube videos about chemotherapy for children	9
New therapeutics for children with sickle cell disease: A time for celebration, caution, or both?	9
Erratum	9
Associations Between Pain Scores and Opioid Doses With Emergency Department Disposition and Return Visit Rates in Children With Sickle Cell Disease	9
Issue Information	9
Cyclin D2 gene variance and expression level in pediatric acute lymphoblastic leukemia	9
Correction to “Salvage Therapy Efficacy is Modified by Risk Group at Diagnosis in Patients With Relapsed Rhabdomyosarcoma”	9
Familial hemophagocytic lymphohistiocytosis onset as central diabetes insipidus in a child	9
Use of milrinone to support therapy‐induced heart failure through hematopoietic stem cell transplantation in a pediatric patient with high‐risk FLT3+ acute myeloid leukemia	9
Continuous blood purification successfully treated severe cytokine release syndrome and immune effector cell‐associated neurotoxicity syndrome after chimeric antigen receptor T‐cell therapy: A case re	9
NCI intramural program approach to rare tumors: Natural history study of rare solid tumors in children and adults: A longitudinal, comprehensive data and biospecimen collection protocol	9
Pediatric Acute B‐Lymphoblastic Leukemia Presenting as Hypereosinophilia With Lung Involvement and Elevated Immunoglobulin E Levels	9
Can you hear me now? Tools for cultivating a culture of respect, value, and appreciation within pediatric hematology, oncology, and cellular therapy	8
Strategies to improve communication about neurocognitive impacts in pediatric oncology: Quality improvement findings	8
Feasibility of a prospective physiotherapy model of care during the intense treatment phase of childhood cancer (FITChild): A mixed methods design	8
Bilirubin crystals in neutrophils of a newborn with Rh incompatibility	8
Coagulopathy and related complications following sclerotherapy of congenital venous malformations	8
Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma	8
Comparison of transfusion reactions in children and adults: A systematic review and meta‐analysis	8
Effects of COVID‐19 vaccination on platelet counts and bleeding in children, adolescents, and young adults with immune thrombocytopenia	8
Comment on: Trends in blood transfusion, hydroxyurea use, and iron overload among children with sickle cell disease enrolled in Medicaid, 2004–2019. Emerging therapeutic options for sickle cell anemia	8
A systematic review of combined surgery and brachytherapy approaches for children and young people with relapsed and refractory rhabdomyosarcoma (Local‐REFoRMS)	8
Sacrococcygeal teratoma: Long‐term outcomes. A UK CCLG Surgeons Group Nationwide Study	8
Development and psychometric analysis of a Pediatric Oncology Nurses’ Educational Needs Scale	8
Use of gemcitabine, oxaliplatin, and anti‐CD20 therapy in children and adolescents with non‐Hodgkin lymphoma unfit for intensive therapy	8
The pervasive influence of systems of power on transition readiness for adult care in sickle cell disease: A qualitative study	8
BRAF‐V600E mutations in plasma and peripheral blood mononuclear cells correlate with prognosis of pediatric Langerhans cell histiocytosis treated with first‐line therapy	8
Data standards in pediatric oncology: Past, present, and future	8
Pediatric severe factor XI deficiency: A multicenter study	8
A congenital CSF3R mutation in chronic neutropenia reveals a vital role for a cytokine receptor extracellular hinge motif in the response to granulocyte colony‐stimulating factor	8
	8
Reducing ambulatory central line‐associated bloodstream infections: A family‐centered approach	8
Blinatumomab overcomes poor prognostic impact of measurable residual disease in pediatric high‐risk first relapse B‐cell precursor acute lymphoblastic leukemia	8
Combinatorial effects of azacitidine and trametinib on NRAS‐mutated melanoma	8
Effects of a Low Versus Moderate–High Intense Exercise Program on Innate Immune Recovery, Fitness, and Quality of Life During Pediatric Allo‐HSCT—The ANIMAL Exploratory Randomized Controlled Trial	8
Prognostic value of hemogram parameters in osteosarcoma: The French OS2006 experience	8
Caregiver perceptions of child heath behaviors and weight during treatment for acute lymphoblastic leukemia	8
Reply to: Comment on: Membrane‐type 1 matrix metalloproteinase as predictor of survival and candidate therapeutic target in Ewing sarcoma	8
Exploring height outcomes with adjuvant aromatase inhibition in growth hormone–deficient male survivors of childhood cancer	8
Hodgkin lymphoma involving the sternum	8
Can virtual care reduce treatment burden in pediatric leukemia? A retrospective cost analysis	8
Myelodysplastic syndrome in a patient with Barth syndrome (3‐methylglutaconic aciduria type II)	8
The Dangerousness of a Devilled Egg	8
Development of a blueprint for sibling psychosocial services: A nationwide study	8
	8
Risk factors for parental divorce in children with cancer	8
Prognostic value of chest x‐ray‐ and CT‐defined large mediastinal adenopathy in high‐risk pediatric Hodgkin lymphoma: A report from the Children's Oncology Group Study AHOD0831	8
SARS‐CoV‐2 vaccine acceptability among caregivers of childhood cancer survivors	8
	8
Rhabdoid tumor predisposition syndrome: A historical review of treatments and outcomes for associated pediatric malignancies	8
Phase 1 study of sorafenib and irinotecan in pediatric patients with relapsed or refractory solid tumors	8
Episodes of acute methotrexate‐related neurotoxicity linked to compromised long‐term neurocognitive function	8